UK markets closed
NIKKEI 225
38,073.98 -128.42 (-0.34%) HANG SENG
18,537.81 +223.91 (+1.22%) CRUDE OIL
79.26 +0.27 (+0.34%) GOLD FUTURES
2,340.30 +18.00 (+0.78%) DOW
39,387.76 +331.37 (+0.85%) Bitcoin GBP
49,927.02 +751.07 (+1.53%)
NewAmsterdam Pharma Company N.V. (KH6.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 03:29PM CEST
| Previous close | 19.60 |
| Open | 19.30 |
| Bid | 19.30 x N/A |
| Ask | 21.00 x N/A |
| Day's range | 19.20 - 19.30 |
| 52-week range | 5.40 - 22.80 |
| Volume | |
| Avg. volume | 6 |
| Market cap | 1.773B |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
NewAmsterdam Pharma Full Year 2023 Earnings: Revenues Miss Expectations
NewAmsterdam Pharma ( NASDAQ:NAMS ) Full Year 2023 Results Key Financial Results Revenue: US$14.1m (down 87% from FY...
- GuruFocus.com
NewAmsterdam Pharma Co NV (NAMS) Faces Net Loss in 2023 Despite Clinical Progress
Company Advances Clinical Trials and Strengthens Financial Position
- Simply Wall St.
Institutions own 18% of NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) shares but private equity firms control 52% of the company
Key Insights NewAmsterdam Pharma's significant private equity firms ownership suggests that the key decisions are...
© 2024 Yahoo. All rights reserved.